Header Logo

Nupur Mittal

Concepts (99)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
7
2023
239
2.010
Why?
Medical Oncology
5
2023
42
1.510
Why?
Mutation
2
2019
353
1.090
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2016
241
0.900
Why?
Patient Selection
3
2022
206
0.880
Why?
Spectrin
2
2019
2
0.780
Why?
Oncologists
1
2021
2
0.750
Why?
Adolescent
11
2023
2307
0.700
Why?
Leukemia, Large Granular Lymphocytic
1
2020
1
0.700
Why?
Cyclosporine
1
2020
13
0.700
Why?
Gene Expression Regulation, Leukemic
1
2019
2
0.640
Why?
MDS1 and EVI1 Complex Locus Protein
1
2019
3
0.640
Why?
Immunosuppressive Agents
1
2020
140
0.640
Why?
Influenza B virus
1
2019
1
0.630
Why?
Atypical Hemolytic Uremic Syndrome
1
2019
1
0.630
Why?
Membrane Cofactor Protein
1
2019
2
0.630
Why?
Medically Underserved Area
1
2019
15
0.630
Why?
Plasma Exchange
1
2019
12
0.630
Why?
Spherocytosis, Hereditary
1
2018
1
0.620
Why?
Genes, Recessive
1
2018
6
0.620
Why?
Leukemia, Myeloid, Acute
1
2019
50
0.620
Why?
Influenza, Human
1
2019
43
0.610
Why?
MicroRNAs
1
2019
54
0.610
Why?
Epigenesis, Genetic
1
2019
86
0.600
Why?
Antibodies, Monoclonal, Humanized
1
2019
94
0.600
Why?
Health Services Accessibility
1
2019
110
0.590
Why?
Healthcare Disparities
1
2019
89
0.580
Why?
Adrenal Cortex Hormones
1
2019
117
0.580
Why?
Histiocytic Sarcoma
1
2016
2
0.550
Why?
Orbital Neoplasms
1
2016
6
0.540
Why?
Genetic Predisposition to Disease
1
2018
390
0.530
Why?
Child
7
2023
1420
0.520
Why?
Young Adult
8
2023
2069
0.500
Why?
Heavy Chain Disease
1
2015
2
0.480
Why?
Lymphoma, B-Cell, Marginal Zone
1
2015
5
0.480
Why?
Prognosis
4
2020
825
0.450
Why?
Lymphohistiocytosis, Hemophagocytic
1
2014
9
0.450
Why?
Humans
19
2023
28436
0.440
Why?
Osteosarcoma
1
2013
37
0.420
Why?
Membrane Proteins
1
2014
171
0.410
Why?
Clinical Trials as Topic
3
2022
239
0.380
Why?
Bone Neoplasms
1
2013
120
0.380
Why?
Male
9
2020
15291
0.310
Why?
Communication
2
2022
124
0.220
Why?
Quality of Life
3
2023
661
0.220
Why?
Fertility Preservation
1
2022
3
0.210
Why?
Cell Line, Tumor
2
2019
249
0.180
Why?
Quality Improvement
1
2022
161
0.180
Why?
Child Health
1
2020
3
0.170
Why?
Administration, Oral
1
2020
111
0.170
Why?
Infant
2
2018
587
0.170
Why?
RNA Splice Sites
1
2019
2
0.160
Why?
Erythrocyte Membrane
1
2019
3
0.160
Why?
Anemia, Hemolytic, Congenital
1
2019
2
0.160
Why?
RNA Splicing
1
2019
10
0.160
Why?
Mutation, Missense
1
2019
26
0.160
Why?
Oligoribonucleotides
1
2019
1
0.160
Why?
Female
6
2020
15730
0.160
Why?
Xenograft Model Antitumor Assays
1
2019
24
0.160
Why?
Antimetabolites, Antineoplastic
1
2019
17
0.160
Why?
Cross-Sectional Studies
1
2022
933
0.150
Why?
Survival Analysis
1
2019
267
0.150
Why?
Cell Proliferation
1
2019
178
0.150
Why?
Child, Preschool
2
2018
688
0.150
Why?
Apoptosis
1
2019
205
0.150
Why?
DNA Methylation
1
2019
165
0.140
Why?
Myelodysplastic Syndromes
1
2017
33
0.140
Why?
Mice
2
2019
1461
0.140
Why?
Signal Transduction
1
2019
447
0.130
Why?
beta Catenin
1
2017
65
0.130
Why?
Age Factors
1
2019
781
0.130
Why?
Adult
4
2022
8107
0.120
Why?
Nitrogen Mustard Compounds
1
2015
1
0.120
Why?
Bendamustine Hydrochloride
1
2015
7
0.120
Why?
Antibodies, Monoclonal, Murine-Derived
1
2015
28
0.120
Why?
Rituximab
1
2015
49
0.120
Why?
Animals
2
2019
3780
0.110
Why?
Metastasectomy
1
2013
7
0.110
Why?
Neoplasm Recurrence, Local
1
2013
206
0.100
Why?
Magnetic Resonance Imaging
1
2016
1143
0.090
Why?
Retrospective Studies
1
2019
3612
0.080
Why?
Lung Neoplasms
1
2013
553
0.070
Why?
Treatment Outcome
1
2016
3615
0.070
Why?
Risk Factors
1
2013
2408
0.070
Why?
Cancer Care Facilities
1
2023
7
0.050
Why?
Survivors
1
2022
71
0.050
Why?
Technology
1
2021
5
0.050
Why?
Delivery of Health Care
1
2023
157
0.050
Why?
Pandemics
1
2021
260
0.040
Why?
Clinical Trials, Phase II as Topic
1
2018
21
0.040
Why?
Chromosomes, Human, Pair 5
1
2017
4
0.040
Why?
Chromosome Deletion
1
2017
16
0.040
Why?
Heterografts
1
2017
15
0.040
Why?
Flow Cytometry
1
2017
116
0.030
Why?
Blotting, Western
1
2017
148
0.030
Why?
Mice, Transgenic
1
2017
225
0.030
Why?
Randomized Controlled Trials as Topic
1
2018
330
0.030
Why?
Infant, Newborn
1
2018
654
0.030
Why?
United States
1
2018
2201
0.020
Why?
Mittal's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (99)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_